Furthermore, previous recent work of others have already identified the existence of an mTOR-ZEB1 signaling axis in GBM using various functional attempts, which we now confirm in the context of a therapeutic relevant pharmacological in vitro model [44,45,46]. The gene discussed is MTOR; the disease is glioblastoma.